Security Snapshot

PROKIDNEY CORP. - Class A Common Stock (PROK) Institutional Ownership

CUSIP: 74291D104

13F Institutional Holders and Ownership History from Q2 2025 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

70

Shares (Excl. Options)

47.76MFull value: 47,755,798 · shares · 30 Jun 2026

Price

$2.04

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Class A Common Stock
Symbol
PROK on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
47,755,798
Latest holder snapshot 5 signals
Total 13F value
$97,411,003
Portfolio coverage rank
0%
Share change
+5,092,417
Value change
+$11,014,270
Number of holders
70
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
205,399,064
SEC-reported price per share
$1.66
Insider filing price
$1.66
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • PROK - PROKIDNEY CORP. - Class A Common Stock is tracked under CUSIP 74291D104.
  • 70 institutions reported positions in Q2 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 69 to 70 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $76.35MFull value: $76,353,029 · USD · 31 Mar 2026
    to
    $97.41MFull value: $97,411,003 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 70 institutions filings for Q2 2026.

Open SEC evidence

Security key

74291D104

13F reference period

Q2 2026

13F holders

70

13D/G owners

2

CIK / CUSIP context first

Open Q2 2026 holders PROK full holder history PROKIDNEY CORP. SEC filings PROKIDNEY CORP. company facts PROKIDNEY CORP. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
PROK
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Control Empresarial de Capitales S.A. de C.V. 36% $132,052,942 73,842,723 Control Empresarial de Capitales S.A. de C.V. 28 Apr 2026
MORGAN STANLEY 4.7% -22% $15,542,547 +$1,825,376 9,653,756 +13% Morgan Stanley 30 Jun 2026
As of 30 Jun 2026, 70 institutional investors reported holding
47.76MFull value: 47,755,798 · shares · 30 Jun 2026
shares of PROKIDNEY CORP. - Class A Common Stock (PROK). This represents 23% of the company’s total
205.4MFull value: 205,399,064 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
23%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
MONTANOVA CAPITAL, LLC 6% 12,341,266 0% 0.53% $25,176,183
MORGAN STANLEY 4.8% 9,854,178 +10% 0% $20,102,523
BlackRock, Inc. 2.5% 5,197,227 +275% 0% $10,602,343
GEODE CAPITAL MANAGEMENT, LLC 1.2% 2,390,147 +94% 0% $4,877,226
Bleichroeder LP 0.97% 2,000,000 0% 0.73% $4,080,000
Hennion & Walsh Asset Management, Inc. 0.9% 1,847,749 +15% 0.11% $3,769,408
Artia Global Partners LP 0.88% 1,806,939 0% 0.7% $3,686,156
VANGUARD CAPITAL MANAGEMENT LLC 0.57% 1,175,257 +2.5% 0% $2,397,524
RENAISSANCE TECHNOLOGIES LLC 0.54% 1,099,400 -12% 0% $2,242,776
MILLENNIUM MANAGEMENT LLC 0.51% 1,054,705 -54% 0% $2,151,598
STATE STREET CORP 0.51% 1,045,945 +88% 0% $2,133,728
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.38% 781,729 +25% 0% $1,594,727
UBS Group AG 0.33% 671,447 +101% 0% $1,369,752
NORTHERN TRUST CORP 0.32% 664,827 +175% 0% $1,356,247
MYDA Advisors LLC 0.31% 640,775 +49% 0.32% $1,307,181
VANGUARD FIDUCIARY TRUST CO 0.31% 632,149 +17% 0% $1,289,584
BANK OF AMERICA CORP /DE/ 0.27% 545,158 -28% 0% $1,112,122
VANGUARD PORTFOLIO MANAGEMENT LLC 0.25% 517,082 0% $1,054,847
Voleon Capital Management LP 0.23% 473,307 +361% 0.02% $965,546
Amundi 0.15% 304,151 +4.3% 0% $620,468
GSA CAPITAL PARTNERS LLP 0.15% 301,622 +48% 0.04% $615,000
TWO SIGMA INVESTMENTS, LP 0.13% 273,259 -21% 0% $557,448
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.12% 252,906 +24% 0% $515,928
GOLDMAN SACHS GROUP INC 0.1% 203,006 -52% 0% $414,132
Virtus Investment Advisers, LLC 0.1% 199,510 +62% 0.09% $407,000

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
6
Headline period
Q2 2026
Rows shown
1-6 of 6
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 2,383,923 $3,956,653 +$735,637 $1.66 15
2026 Q2 47,755,798 $97,411,003 +$11,014,270 $2.04 70
2026 Q1 42,655,656 $76,353,029 +$964,134 $1.79 69
2025 Q4 41,945,569 $93,958,103 +$18,974,610 $2.24 62
2025 Q3 33,452,097 $80,954,450 +$79,786,213 $2.42 55
2025 Q2 527,620 $311,428 +$311,428 $0.59 5
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .